Form 4: Fulgent Genetics CFO Paul Kim Reports Tax Withholding Transaction
SEC Form 4 Filing
CFO and Treasurer of Fulgent Genetics, Paul Kim, reports the withholding of 3,000 common stock shares to cover tax obligations related to vesting restricted stock units.
Summary
- On January 26, 2025, Paul Kim, CFO and Treasurer of Fulgent Genetics, Inc., reported a transaction involving the withholding of 3,000 shares of common stock.
- The shares were withheld to satisfy tax obligations arising from the vesting of restricted stock units.
- The price per share was $17.21.
- Following the transaction, Kim directly owns 201,521 shares of Fulgent Genetics common stock.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing regarding tax withholding, indicating a neutral sentiment.
Industry Context
This Form 4 filing is a routine disclosure related to executive compensation and tax obligations, common in publicly traded companies. It provides transparency into the transactions of company insiders.
Comparison to Industry Standards
- Form 4 filings are standard practice for publicly traded companies, ensuring transparency regarding insider transactions.
- The tax withholding process described is a common method for handling tax obligations related to equity compensation, aligning with standard industry practices.
Stakeholder Impact
- The transaction has a minimal direct impact on stakeholders, as it is a routine tax withholding event.
- It provides transparency to shareholders regarding executive compensation and insider transactions.
Key Dates
| Date | Description |
|---|---|
| November 7, 2022 | Date of the Agreement and Plan of Merger by and among Fulgent Genetics, Inc., FG Merger Sub, Inc., Fulgent Pharma Holdings, Inc., and the stockholders listed therein. |
| November 9, 2022 | Date of Form 4 filing with the U.S. Securities and Exchange Commission reporting the awards originally. |
| January 26, 2025 | Date of the reported transaction where 3,000 shares were withheld for tax obligations. |
| January 28, 2025 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.